Special Issue: Mucorales and Mucormycosis
- PMID: 31877973
- PMCID: PMC7151165
- DOI: 10.3390/jof6010006
Special Issue: Mucorales and Mucormycosis
Abstract
Mucormycosis is a life-threatening infection, occurring mainly in immunocompromised patients, but also in immunocompetent patients after traumatic injuries [...].
Conflict of interest statement
The author declares no conflict of interest.
References
-
- Cornely O.A., Arikan-Akdagli S., Dannaoui E., Groll A.H., Lagrou K., Chakrabarti A., Lanternier F., Pagano L., Skiada A., Akova M., et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin. Microbiol. Infect. 2014;20(Suppl. 3):5–26. doi: 10.1111/1469-0691.12371. - DOI - PubMed
-
- Caramalho R., Tyndall J.D.A., Monk B.C., Larentis T., Lass-Florl C., Lackner M. Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14alpha-demethylase. Sci. Rep. 2017;7:15898. doi: 10.1038/s41598-017-16123-9. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
